5 Organisation and delivery of psychiatric services5.3 Provision of specific treatments

5.3.2 DBS, rTMS and psychosurgery

2 min read2 figures

Written by Resident Doctor Committee · Published

Three levels of invasiveness

Technique

Invasiveness

Reversibility

Mechanism

Repetitive transcranial magnetic stimulation (rTMS)

Scalp coil, no surgery

Stimulation stops at once

Magnetic pulses induce cortical currents

Deep brain stimulation (DBS)

Implanted electrodes and chest-wall pulse generator

Can be switched off, but surgery has lasting risks

Modulates a targeted circuit without a lesion

Psychosurgery

Targeted brain lesion

Irreversible

Destroys a small volume of tissue in a chosen circuit

rTMS

  • Sham-controlled randomised trials support rTMS in depression, most strongly in unipolar depression that has not responded to antidepressants.

  • Depression protocols aim high-frequency stimulation at the left dorsolateral prefrontal cortex.

  • Patients are treated awake as outpatients, without anaesthesia or admission, on weekdays for 4 to 6 weeks.

  • National Institute for Health and Care Excellence (NICE) interventional procedures guidance IPG542 finds no major safety concerns and adequate short-term efficacy with variable response.

  • Under IPG542, rTMS for depression may be used under normal governance and audit arrangements.

  • For obsessive-compulsive disorder (OCD), rTMS needs special arrangements or research, and other conditions have no NICE support.

Find the dorsolateral prefrontal cortex, shaded green at the upper front of the frontal lobe: the left side of this region is where depression protocols aim high-frequency rTMS. Eko321, CC0, via Wikimedia Commons

Adverse effects and contraindications

  • Headache from stimulation of scalp muscles and nerves under the coil is the most common side effect, and it is mild and self-limiting.

  • Implanted metal or electronic hardware in or near the head contraindicates rTMS, because the coil's magnetic field can heat, move or disrupt it, as with a ferromagnetic implant.

DBS

  • DBS is an invasive neurosurgical treatment: surgeons implant electrodes and hardware in the brain, and stimulation can then be adjusted without further surgery.

  • Treatment-refractory OCD is the only psychiatric indication with an established evidence base: sham-controlled crossover trials, consistent responder rates and regulatory approval.

  • In other psychiatric disorders DBS is experimental, mixed in its results or unstudied.

  • In depression, the sham-controlled BROADEN trial stopped early for futility.

  • For OCD, DBS targets the anterior limb of the internal capsule.

  • Surgical risks include intracranial haemorrhage and infection, and hardware infection reaches around 5% in some series.

  • Stimulation can cause hypomania, disinhibition, impulsivity, hypersexuality, apathy or low mood.

Psychosurgery

Year

Event

1935

Egas Moniz conceived the first prefrontal leucotomy and Almeida Lima performed it

1936

Freeman adapted it with Watts

1946

Freeman devised the transorbital route

  • Early operations were imprecise and harmful, and use fell sharply with psychotropic treatment.

  • Neurosurgery for mental disorder is now reserved for a very narrow set of chronic, treatment-refractory conditions, with intractable OCD the accepted last-line indication in current UK practice.

  • Modern operations make stereotactic lesions in limbic circuits, and only uncontrolled case series support them.

Procedure

Target

Anterior cingulotomy

Anterior cingulate cortex and cingulate bundle

Anterior capsulotomy

Anterior limb of the internal capsule

Subcaudate tractotomy

Substantia innominata beneath the caudate nucleus

Limbic leucotomy

Subcaudate tractotomy plus anterior cingulotomy

Follow the cortico-striato-thalamo-cortical loop in OCD: anterior cingulotomy lesions the anterior cingulate and cingulum bundle, and anterior capsulotomy cuts frontothalamic fibres in the anterior limb of the internal capsule. Drawn for MRCPsychiatrist

Law on psychosurgery

  • In England and Wales, section 57 of the Mental Health Act 1983 covers operations that destroy brain tissue, in detained and informal patients alike.

  • It needs the patient's valid consent and independent certification, with no route for a patient who lacks capacity and no emergency override.